Skip to content

Efficacy test of the oral composition

Ingestion test of the oral composition - Efficacy test of the oral composition

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000049704
Enrollment
40
Registered
2022-12-09
Start date
2022-12-09
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gingivitis

Interventions

Ingest T0210 three times a day for 8wks. Ingest placebo three times a day for 8wks.

Sponsors

Kao Corporation
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Male and female aged 20-65 2. Those who have gingival inflammation that falls under any of the following A, B, or C A. When brushing your teeth, the gums may bleed. B. Gingiva may swell C. At dental offices and dental checkups, it has been pointed out that the gums are swollen and the periodontal pockets are deep.

Exclusion criteria

Exclusion criteria: (1) Those suffering from systemic diseases (diabetes, heart disease, kidney disease, liver disease, congenital heart disease, etc.) (2) Those who are taking drugs to improve glucose metabolism and lipid metabolism, or antihypertensive drugs (3) Those who plan to consume foods for specified health uses, foods with function claims, and dietary supplements (supplement foods such as capsules) that are considered to affect this study during the study period (which appeal to triglycerides, blood sugar, blood pressure, cholesterol, and body fat) (4) Those who have obvious trauma in the oral cavity (5) Those who are visiting a medical institution due to severe periodontal disease or oral disease (6) Those who have been prescribed antibiotics at a dental clinic due to gingival swelling within one year (7) Those who have had fever or respiratory symptoms in themselves or a family member living with them from one week before the measurement date, or those who have been in close contact with a person infected with the covid-19. (8) Those who use mouthwash on a daily basis (e.g., isodine mouthwash, clean mouthwash, gargle fresh, etc.) (9) Those who have collected 200 mL or more of blood (blood donation, etc.) within one month of the start of this study or 400 mL within three months. (10) Those who have severe anemia in the most recent medical examination (11) Those who have experienced side effects (feeling sick, dizziness, nausea, collapse, etc.) after blood collection (12) Those who have been allergic to sugar alcohols such as xylitol and erythritol in the past (13) Those who, for other reasons, are judged to be ineligible for the test by the dentist in charge of the trial or the director of the test and research.

Design outcomes

Primary

MeasureTime frame
Gingival condition before and after 8wks application

Secondary

MeasureTime frame
Ratio of specific bacteria in plaque

Countries

Japan

Contacts

Public ContactTeppei Tajikara

Kao Corporation Personal Health Care Products Research Lab.

tajikara.teppei@kao.com+81-3-5630-9747

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026